Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check4 days agoChange Detected- Revision: added v3.5.0; removed v3.4.3.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.4.2 was added to the page. The government funding lapse notice and Revision: v3.4.1 notice were removed.SummaryDifference0.3%

- Check47 days agoChange DetectedAdded a government funding/operations notice at the top of the page and updated the site release to Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check54 days agoChange DetectedGlossary display added and QC-related metadata updated with a new Revision: v3.4.0; the label wording around the QC update has been standardized (and capitalization adjusted) compared to the previous version.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; a minor backend update with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.